|Videos|August 24, 2020

The Need for Fixed Healthcare, Post-COVID

An infectious disease chief medical officer discusses the cracks in US healthcare exposed by the pandemic.

The ongoing coronavirus 2019 (COVID-19) pandemic shines an ugly light on the flaws of public health response capability and prioritization of resources.

As much can be observed in reports of PPE shortages, ventilator needs, and concerns over costs for antiviral agents that could mean the different between a severe patient going to the ICU, or going home.

But to some, the light is not shined on the parts of the system, but on the entire system itself. Many people call for the reprioritization of funding or systemic changes to the means by which eligible candidates can become clinicians. They want more doctors, or better, affordable resources.

Brad Spellberg, MD, chief medical officer of the Los Angeles County and University of Southern California Medical Center, has put such challenges to pen and paper.

The author of the book Broken, Bankrupt and Dying, published in June, talked with Contagion recently on the subject of COVID-19’s effect on exposing US healthcare system flaws—as well as the limitations of the infectious disease subspecialty.

Spellberg noted the greatest issue in private healthcare-facing system is being exacerbated right now by the pandemic: COVID-19 has affected the economic status as significant as it has the healthcare system.

“I think we also can speak to the fact that we don’t have enough ID specialists in the United States to handle public health crises and global pandemics, because our specialty is not aligned with the predominant market forces of the fee-for-service health system, which the US remains in, while most other health systems do not,” he said.


Related to this article

Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.